Opinions of Turkish physicians about the participation of patients and/or patient caregivers in multidisciplinary tumor boards; A survey study from tertiary Center in Konya.

Yıl 2023, Cilt: 33 Sayı: 4, 430 - 433, 31.08.2023

Orhan Önder Eren Melek Çağlayan Muslu Kazım Körez

https://doi.org/10.54005/geneltip.1271115

Öz

Opinions of Turkish physicians about the participation of patients and/or patient caregivers in multidisciplinary tumor boards; A survey study from tertiary Center in Konya.
Abstract
Objective: Multidiscplinary management is very important component of treatment of cancer. Multidisciplinary tumor boards (MB) provide the chance for shared-decision making in this complex type of disease. The participation of patients or caregivers in MB is a contentious issue and is not common in Turkey. In this study we aimed to determine what Turkish physicians participating MTBs in Selcuk University Faculty of Medicine think about the participation of patients and caregivers in MTBs.
Method: The study was conducted in Selcuk University Faculty of Medicine in August 2022. The physicians that accepted to participate completed a 9-item questionnaire. The relationships between the participants’ sociodemographic characteristics and their questionnaire responses concerning MTBs were analyzed using Pearson’s chi-square test or the Fisher-Freeman-Halton test.
Results: No statistically significant correlation was found between the socio-demographic characteristics of the participants and the opinions of cancer patients or their relatives about their participation in multidisciplinary tumor boards. 50 % of the participants do not approve participation of patient or caregivers in MTBs. 35 % of participants approve the participation of both in the MB. 4.4 % of participants approve only the participation of caregivers whereas only the 8.9 % of medical oncologist approve only the participation of patients in tumor board.
Conclusion: Among 45 Turkish physicians in a tertiary care center, half of the participants do not approve of the participation of patients or caregivers in MTBs. The major reason for this lack of approval is fear that patients and caregivers will not understand medical terminology which may lead to misunderstanding by patients or caregivers.

Anahtar Kelimeler

Cancer, multidisciplinary tumor board, physicians.

Opinions of Turkish Physicians About the Participation of Patients and/or Patient Caregivers in Multidisciplinary Tumor Boards; A Survey Study From Tertiary Center in Konya

Öz

Abstract
Objective: Multidiscplinary management is very important component of treatment of cancer. Multidisciplinary tumor boards (MB) provide the chance for shared-decision making in this complex type of disease. The participation of patients or caregivers in MB is a contentious issue and is not common in Turkey. In this study we aimed to determine what Turkish physicians participating MTBs in Selcuk University Faculty of Medicine think about the participation of patients and caregivers in MTBs.
Method: The study was conducted in Selcuk University Faculty of Medicine in August 2022. The physicians that accepted to participate completed a 9-item questionnaire. The relationships between the participants’ sociodemographic characteristics and their questionnaire responses concerning MTBs were analyzed using Pearson’s chi-square test or the Fisher-Freeman-Halton test.
Results: No statistically significant correlation was found between the socio-demographic characteristics of the participants and the opinions of cancer patients or their relatives about their participation in multidisciplinary tumor boards. 50 % of the participants do not approve participation of patient or caregivers in MTBs. 35 % of participants approve the participation of both in the MB. 4.4 % of participants approve only the participation of caregivers whereas only the 8.9 % of medical oncologist approve only the participation of patients in tumor board.
Conclusion: Among 45 Turkish physicians in a tertiary care center, half of the participants do not approve of the participation of patients or caregivers in MTBs. The major reason for this lack of approval is fear that patients and caregivers will not understand medical terminology which may lead to misunderstanding by patients or caregivers.

Anahtar Kelimeler

Cancer, multidisciplinary tumor board, physicians.

Kaynakça

• Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012 Apr 26;344:e2718. doi: 10.1136/bmj.e2718
• Specchia ML, Frisicale EM, Carini E, Di Pilla A, Cappa D, Barbara A, Ricciardi W, Damiani G. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res. 2020 Jan 31;20(1):73. doi: 10.1186/s12913-020-4930-3.
• Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL. Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol. 2006 Mar;17(3):457-60. doi: 10.1093/annonc/mdj102.
• Liu JC, Kaplon A, Blackman E, Miyamoto C, Savior D, Ragin C. The impact of the multidisciplinary tumor board on head and neck cancer outcomes. Laryngoscope. 2020 Apr;130(4):946-950. doi: 10.1002/lary.28066.
• Brandão M, Guisseve A, Damasceno A, Bata G, Silva-Matos C, Alberto M, Ferro J, Garcia C, Zaqueu C, Lorenzoni C, Leitão D, Soares O, Gudo-Morais A, Schmitt F, Morais S, Tulsidás S, Carrilho C, Lunet N. Risk Factors for Breast Cancer, Overall and by Tumor Subtype, among Women from Mozambique, Sub-Saharan Africa. Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1250-1259. doi: 10.1158/1055-9965.EPI-20-1730.
• Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, Crowe J, Costello AJ. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2016 Jan; 42:56-72. doi: 10.1016/j.ctrv.2015.11.007.
• Ansmann L, Heuser C, Diekmann A, Schellenberger B, Biehl C, Danaei M, Eichler C, Heinz D, Hocke A, Malter W, Melekian B, Metin H, Mustea A, Palatty J, Peisker U, Petschat I, Ernstmann N. Patient participation in multidisciplinary tumor conferences: How is it implemented? What is the patients' role? What are patients' experiences? Cancer Med. 2021 Oct;10(19):6714-6724. doi: 10.1002/cam4.4213.
• Ansmann L, Kowalski C, Pfaff H, Wuerstlein R, Wirtz MA, Ernstmann N. Patient participation in multidisciplinary tumor conferences. Breast. 2014 Dec;23(6):865-9. doi: 10.1016/j.breast.2014.09.004.
• Diekmann A, Heuser C, Ernstmann N, Geiser F, Groß SE, Midding E, Pfaff H, Ansmann L. How do breast cancer patients experience multidisciplinary tumor conferences? - A description from the patient perspective. Breast. 2019 Apr;44:66-72. doi: 10.1016/j.breast.2018.12.012.
• Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs. 2008 Sep;12(4):299-318. doi: 10.1016/j.ejon.2008.03.004.
• Klein SD, Bucher HU, Hendriks MJ, Baumann-Hölzle R, Streuli JC, Berger TM et al.Sources of distress for physicians and nurses working in Swiss neonatal intensive care units. Swiss Med Wkly. 2017 Aug 3;147:w14477. doi: 10.4414/smw.2017.14477.
• Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res. 2018 Apr 5;18(1):249. doi: 10.1186/s12913-018-2990-4.
• Mano MS, Çitaku FT, Barach P. Implementing multidisciplinary tumor boards in oncology: a narrative review. Future Oncol. 2022 Jan;18(3):375-384. doi: 10.2217/fon-2021-0471.
• Frank B, Ihorst G, Herget G, Schäfer H, Neubauer J, Calba MA et al. Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers. Ann Hematol. 2023 Mar;102(3):603-611. doi: 10.1007/s00277-022-05051-y.